Form EFFECT Evoke Pharma Inc
Tweet
Share
E-mail| UNITED STATES | |
| SECURITIES AND EXCHANGE COMMISSION | |
| Washington, D.C. 20549 | |
| Notice of Effectiveness | |
| Effectiveness Date: | December 18, 2025 |
| Accession Number: | 0001193125-25-322647 | ||||||
| Submission Type: | POS AM | ||||||
| |||||||
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- InvestorNewsBreaks – AmpliTech Group Inc. (NASDAQ: AMPG) to Present Advanced Connectivity Solutions at Investor Conference
- InvestorNewsBreaks – Millennial Potash Corp. (OTCQB: MLPNF) (FSE: X0D) Heads to New York for Disruptive Conference
- Robert Stitzel Scholarship for Entrepreneurs Launches to Fund Undergraduate Innovation across the US
Create E-mail Alert Related Categories
SEC FilingsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
